# AsclepiX Therapeutics, Inc. — Form D

AsclepiX Therapeutics, Inc. of Bethesda, MD, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-26. The offering totals $12.5M, of which $10.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-04-26
- Form: D
- Accession: 0001697751-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.5M
- Amount sold: $10.0M
- Remaining: $2.5M
- Investors: 9
- Date of first sale: 2023-07-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-511712

## Issuer

- Name: AsclepiX Therapeutics, Inc.
- CIK: 0001697751
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 5237 River Road, Bethesda, MD, 20816
- Phone: 610-212-1217

## Officers, directors & promoters (25)

| Name | Role | Location |
| --- | --- | --- |
| Steven Altschuler | Director | WATERTOWN, MA |
| Ben Askew | Director | Bethesda, MD |
| Josh Barer | Director | Bethesda, MD |
| Chris Garabedian | Director | San Francisco, CA |
| Jordan Green | Director | Bethesda, MD |
| Sapna Srivastava | Director | Bethesda, MD |
| Robert Dempsey | Executive Officer | Bethesda, MD |
| Niranjan Pandey | Executive Officer | Bethesda, MD |
| Aleksander Popel | Executive Officer | Bethesda, MD |
| Amir Shojaei | Executive Officer | Bethesda, MD |
| Jill Tierney | Executive Officer | Bethesda, MD |
| Jordan J Green | Director | Porte Vedra Beach, FL |
| Jordan J Green | Executive Officer | Porte Vedra Beach, FL |
| Joshua Barer | Director | Rochester, MI |
| Sapna S Srivastava | Director | Baltimore, MD |
| Aleksander S Popel, PhD | Director | Baltimore, MD |
| Aleksander S Popel, PhD | Executive Officer | Baltimore, MD |
| Kevin S Slawin, MD | Director | Baltimore, MD |
| Kevin S Slawin, MD | Executive Officer | Baltimore, MD |
| Steven S Altschuler, MD | Director | Baltimore, MD |
| Joshua S Barer | Director | Baltimore, MD |
| Wendy Perrow | Director | Baltimore, MD |
| Wendy Perrow | Executive Officer | Baltimore, MD |
| Aleksander Popel, PhD | Director | Baltimore, MD |
| Kevin Slawin, MD | Director | Baltimore, MD |

## Other filings by this issuer (4)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-06-11](https://search.stillhousedata.com/formd/0001697751-20-000001) | D | $35.0M | $10.0M |
| [2019-06-17](https://search.stillhousedata.com/formd/0001697751-19-000001) | D/A | $10.0M | $7.7M |
| [2018-10-25](https://search.stillhousedata.com/formd/0001697751-18-000004) | D | $7.5M | $3.9M |
| [2017-02-09](https://search.stillhousedata.com/formd/0001697751-17-000001) | D | $1.0M | $175K |

## More

- [CIK 1697751 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1697751&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001697751-24-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.